Noticias de Eulerpool Vivoryon Therapeutics

Vivoryon Therapeutics Noticias de Acciones

Vivoryon Therapeutics es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Vivoryon Therapeutics.

• 6 de junio ·

  Yahoo
  Vivoryon Therapeutics N.V. Presents Meta-analysis Data of VIVIAD and VIVA-MIND studies at ERA 2025
• 27 de mayo ·

  Yahoo
  Vivoryon Therapeutics N.V. Expands Intellectual Property Portfolio with New U.S. Composition of Matter Patent Granted for Varoglutamstat
• 13 de mayo ·

  Yahoo
  Vivoryon Therapeutics N.V. to Hold its 2025 Annual General Meeting on June 24, 2025
• 30 de abril ·

  Yahoo
  Vivoryon Therapeutics NV (FRA:05Y) Q4 2024 Earnings Call Highlights: Strategic Shifts and ...
• 24 de abril ·

  Yahoo
  Vivoryon Therapeutics N.V. Signs Financing Agreement for up to EUR 15 Million
• 17 de abril ·

  Yahoo
  Vivoryon Therapeutics N.V. to Report Full Year 2024 Financial Results and Operational Progress on April 29, 2025
• 1 de marzo ·

  Yahoo
  Here's Why We're Watching Vivoryon Therapeutics' (AMS:VVY) Cash Burn Situation
• 19 de febrero ·

  Yahoo
  Vivoryon Therapeutics N.V. Shares Highlights from Virtual R&D Update with KOL Speakers
• 11 de febrero ·

  Yahoo
  Vivoryon Therapeutics N.V. to Host Virtual R&D Update with KOL Speakers on February 18, 2025
• 14 de enero ·

  Yahoo
  Vivoryon Therapeutics N.V. Provides R&D-Update Further Strengthening Development Pipeline in Kidney Disease